Third degree AV block natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Third degree AV block}}
{{Third degree AV block}}
{{CMG}}; {{AE}} {{Soroush}} {{RT}}
{{CMG}}; {{AE}} {{Soroush}} {{RT}} ; {{ADG}}


==Overview==
==Overview==

Revision as of 03:57, 11 April 2020

Third degree AV block Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Third degree AV block from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Third degree AV block natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Third degree AV block natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Third degree AV block natural history, complications and prognosis

CDC on Third degree AV block natural history, complications and prognosis

Third degree AV block natural history, complications and prognosis in the news

Blogs on Third degree AV block natural history, complications and prognosis

Directions to Hospitals Treating Third degree AV block

Risk calculators and risk factors for Third degree AV block natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2] Raviteja Guddeti, M.B.B.S. [3] ; Aditya Ganti M.B.B.S. [4]

Overview

Spontaneous recovery from third degree heart block is very rare. If left untreated third degree heart block is associated with a high mortality which appears to occur as a consequence of the complications of prematurity and bradycardia owing to the delayed initiation of pacing therapy. Patients with third-degree heart blocks are vulnerable to decreased perfusion related to symptomatic bradycardia and decreased cardiac output. Common complications of third degree AV block include sudden cardiac death due to asystole, syncope and musculoskeletal injuries secondary to fall after syncope. The prognosis of third degree heart block is most likely dependent on the patient's underlying disease burden and severity of the clinical presentation on arrival. Patients treated with permanent pacemaker have an excellent prognosis.

Natural History, Complications, and Prognosis

Natural History

  • Spontaneous recovery from third degree heart block is very rare.
  • The estimated overall mortality of non-paced patients with isolated AV block is 8%–16% in infants and 4%–8% in children and adults.[1][2]
  • If left untreated third degree heart block is associated with a high mortality which appears to occur as a consequence of the complications of prematurity and bradycardia owing to the delayed initiation of pacing therapy.

Complications

Prognosis

  • The prognosis of third degree heart block is most likely dependent on the patient's underlying disease burden and severity of the clinical presentation on arrival.[4]
  • Complete heart block is sometimes reversible in settings such as acute MI by restoring coronary perfusion and in conditions such as Lymes disease by treatment with antibiotics.[5]
  • Patients treated with permanent pacemaker have an excellent prognosis.
  • Patients with complete heart block due to acute myocardial infarction are at a greater risk for sudden cardiac death.

References

  1. Proclemer A, Zecchin M, D'Onofrio A, Ricci RP, Boriani G, Rebellato L, Ghidina M, Bianco G, Bernardelli E, Miconi A, Zorzin AF, Gregori D (March 2019). "[The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2017]". G Ital Cardiol (Rome) (in Italian). 20 (3): 136–148. doi:10.1714/3108.30963. PMID 30821295.
  2. Merchant FM, Hoskins MH, Musat DL, Prillinger JB, Roberts GJ, Nabutovsky Y, Mittal S (June 2017). "Incidence and Time Course for Developing Heart Failure With High-Burden Right Ventricular Pacing". Circ Cardiovasc Qual Outcomes. 10 (6). doi:10.1161/CIRCOUTCOMES.117.003564. PMID 28630373.
  3. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO (January 2013). "2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society". Circulation. 127 (3): e283–352. doi:10.1161/CIR.0b013e318276ce9b. PMID 23255456.
  4. Kosmidou I, Redfors B, Dordi R, Dizon JM, McAndrew T, Mehran R, Ben-Yehuda O, Mintz GS, Stone GW (May 2017). "Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial)". Am. J. Cardiol. 119 (9): 1295–1301. doi:10.1016/j.amjcard.2017.01.019. PMID 28267964.
  5. Harikrishnan P, Gupta T, Palaniswamy C, Kolte D, Khera S, Mujib M, Aronow WS, Ahn C, Sule S, Jain D, Ahmed A, Cooper HA, Jacobson J, Iwai S, Frishman WH, Bhatt DL, Fonarow GC, Panza JA (December 2015). "Complete Heart Block Complicating ST-Segment Elevation Myocardial Infarction: Temporal Trends and Association With In-Hospital Outcomes". JACC Clin Electrophysiol. 1 (6): 529–538. doi:10.1016/j.jacep.2015.08.007. PMID 29759406.


Template:WikiDoc Sources